NEPHROS INC (26)
Browse by Contract Category
Contracts
-
Agreement for Purchase and Sale of Assets, dated October 4, 2022, by and between Nephros, Inc. and BWSI, LLC (pursuant to Item 601(b)(2)(ii) of Regulation S-K, certain information...
(Filed With SEC on November 21, 2022)
-
Certificate of Amendment to Amended and Restated Certificate of Incorporation of Specialty Renal Products, Inc., dated February 4, 2022
(Filed With SEC on May 5, 2022)
-
Separation Agreement and Release, between the Company and Daniel DAgostino, dated January 28, 2021
(Filed With SEC on May 6, 2021)
-
First Amendment to Series A Preferred Stock Purchase Agreement, dated February 1, 2022, among Specialty Renal Products, Inc. and the Purchaser parties identified therein
(Filed With SEC on May 5, 2022)
-
First Amendment to Loan Agreement dated January 19, 2022, between the Company and Specialty Renal Products, Inc
(Filed With SEC on May 5, 2022)
-
Asset Purchase Agreement between Nephros, Inc. and GenArraytion, Inc. dated July 9, 2021
(Filed With SEC on November 4, 2021)
-
Letter Agreement, dated November 30, 2020, between Wesley S. Lobo and the Registrant
(Filed With SEC on March 1, 2021)
-
Letter Agreement dated September 22, 2020, between Dan DAgostino and Nephros, Inc
(Filed With SEC on November 5, 2020)
-
Consulting Agreement between Specialty Renal Products, Inc. and Daron Evans, dated August 26, 2020
(Filed With SEC on November 5, 2020)
-
Consulting Agreement between the Registrant and Daron Evans, dated August 23, 2020
(Filed With SEC on November 5, 2020)
-
Employment Agreement between the Registrant and Andrew Astor, dated August 23, 2020
(Filed With SEC on November 5, 2020)
-
Second Amendment to Membership Interest Purchase Agreement, between the Company and Gregory Lucas, dated October 15, 2020
(Filed With SEC on October 20, 2020)
-
Form of Securities Purchase Agreement dated October 15, 2020, between Nephros, Inc. and the Purchasers
(Filed With SEC on October 16, 2020)
-
8% Convertible Promissory Note, from Specialty Renal Products, Inc. to the Company, dated October 7, 2020
(Filed With SEC on October 13, 2020)
-
Loan Agreement between the Company and Specialty Renal Products, dated October 7, 2020
(Filed With SEC on October 13, 2020)
-
U.S. Small Business Administration Paycheck Protection Program Note dated April 22, 2020, between the Registrant and First Republic Bank
(Filed With SEC on August 5, 2020)
-
Amended and Restated Secured Promissory Note (Single Advance Non-Revolving), dated May 26, 2020, issued by the Registrant
(Filed With SEC on August 5, 2020)
-
Amended and Restated Loan and Security Agreement, dated May 26, 2020, by and between Tech Capital, LLC and the Registrant
(Filed With SEC on August 5, 2020)
-
First Amendment to Membership Interest Purchase Agreement, dated June 24, 2020, by and between the Registrant and Gregory Lucas
(Filed With SEC on August 5, 2020)
-
Description of Capital Stock
(Filed With SEC on February 27, 2020)
-
Underwriting Agreement dated January 31, 2020, between Nephros, Inc. and Craig-Hallum Capital Group LLC
(Filed With SEC on January 31, 2020)
-
First Modification to Loan and Security Agreement dated December 20, 2019, between Nephros, Inc. and Tech Capital, LLC
(Filed With SEC on December 26, 2019)
-
Form of Stock Purchase Agreement, dated May 15, 2019, among Nephros, Inc. and the Purchasers identified therein
(Filed With SEC on May 16, 2019)
-
First Amendment to Employment Agreement between Nephros, Inc. and Daron Evans, effective April 15, 2019
(Filed With SEC on May 8, 2019)
-
Membership Interest Purchase Agreement, dated December 31, 2018, by and among the Registrant, Biocon 1, LLC, Aether Water Systems, LLC, and Gregory Lucas
(Filed With SEC on March 12, 2019)
-
Second Amendment to Sublicense Agreement, dated January 30, 2019, between the Registrant and CamelBak Products, LLC
(Filed With SEC on March 12, 2019)